These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 19644794)

  • 1. Synergistic anti-candidal activity of tetrandrine on ketoconazole: an experimental study.
    Zhang H; Wang K; Zhang G; Ho HI; Gao A
    Planta Med; 2010 Jan; 76(1):53-61. PubMed ID: 19644794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergistic effects of tetrandrine on the antifungal activity of topical ketoconazole cream in the treatment of dermatophytoses: a clinical trial.
    Shi JP; Zhang H; Zhang ZD; Zhang GH; Gao AL; Xiang SB
    Chin J Integr Med; 2011 Jul; 17(7):499-504. PubMed ID: 21725874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tetrandrine enhances the antifungal activity of fluconazole in a murine model of disseminated candidiasis.
    Shi J; Li S; Gao A; Zhu K; Zhang H
    Phytomedicine; 2018 Jul; 46():21-31. PubMed ID: 30097119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploratory study on the clinical and mycological effectiveness of a herbal medicinal product from Solanum chrysotrichum in patients with Candida yeast-associated vaginal infection.
    Herrera-Arellano A; Jiménez-Ferrer E; Zamilpa A; Martínez-Rivera Mde L; Rodríguez-Tovar AV; Herrera-Alvarez S; Salas-Andonaegui ML; Nava-Xalpa MY; Méndez-Salas A; Tortoriello J
    Planta Med; 2009 Apr; 75(5):466-71. PubMed ID: 19189246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic efficacy of posaconazole against isolates of Candida albicans with different susceptibilities to fluconazole in a vaginal model.
    González GM; Robledo E; Saldívar D; González G; Bosques F; Garza E
    Med Mycol; 2007 May; 45(3):221-4. PubMed ID: 17464843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Azole resistance in Candida albicans.
    Ryley JF; Wilson RG; Barrett-Bee KJ
    Sabouraudia; 1984; 22(1):53-63. PubMed ID: 6322363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic efficacy of voriconazole against a fluconazole-resistant Candida albicans isolate in a vaginal model.
    González GM; Portillo OJ; Uscanga GI; Andrade SE; Robledo M; Rodríguez C; Elizondo M
    J Antimicrob Chemother; 2009 Sep; 64(3):571-3. PubMed ID: 19570754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro interaction between azoles and cyclosporin A against clinical isolates of Candida albicans determined by the chequerboard method and time-kill curves.
    Li Y; Sun S; Guo Q; Ma L; Shi C; Su L; Li H
    J Antimicrob Chemother; 2008 Mar; 61(3):577-85. PubMed ID: 18194958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ibuprofen reverts antifungal resistance on Candida albicans showing overexpression of CDR genes.
    Ricardo E; Costa-de-Oliveira S; Dias AS; Guerra J; Rodrigues AG; Pina-Vaz C
    FEMS Yeast Res; 2009 Jun; 9(4):618-25. PubMed ID: 19416368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antifungal activities of two new azasordarins, GW471552 and GW471558, in experimental models of oral and vulvovaginal candidiasis in immunosuppressed rats.
    Martinez A; Ferrer S; Santos I; Jimenez E; Sparrowe J; Regadera J; De Las Heras FG; Gargallo-Viola D
    Antimicrob Agents Chemother; 2001 Dec; 45(12):3304-9. PubMed ID: 11709301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tetrandrine protects mice from concanavalin A-induced hepatitis through inhibiting NF-kappaB activation.
    Feng D; Mei Y; Wang Y; Zhang B; Wang C; Xu L
    Immunol Lett; 2008 Dec; 121(2):127-33. PubMed ID: 18992279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Vaginal candidiasis: etiology and sensitivity profile to antifungal agents in clinical use].
    Saporiti AM; Gómez D; Levalle S; Galeano M; Davel G; Vivot W; Rodero L
    Rev Argent Microbiol; 2001; 33(4):217-22. PubMed ID: 11833253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of the combination of ketoconazole and calcium channel antagonists against Candida albicans in vitro.
    Krajewska-Kułak E; Niczyporuk W
    Arzneimittelforschung; 1993 Jul; 43(7):782-3. PubMed ID: 8369013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro and in vivo activity of tea tree oil against azole-susceptible and -resistant human pathogenic yeasts.
    Mondello F; De Bernardis F; Girolamo A; Salvatore G; Cassone A
    J Antimicrob Chemother; 2003 May; 51(5):1223-9. PubMed ID: 12668571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro synergistic activity of ketoconazole with valproic acid against Candida species.
    Krajewska-Kułak E; Niczyporuk W
    Arzneimittelforschung; 1996 Sep; 46(9):934-6. PubMed ID: 8876946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro synergism between nyasol, an active compound isolated from Anemarrhena asphodeloides, and azole agents against Candida albicans.
    Iida Y; Oh KB; Saito M; Matsuoka H; Kurata H
    Planta Med; 2000 Jun; 66(5):435-8. PubMed ID: 10909263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antifungal activity of itraconazole and ketoconazole investigated in vitro, determined with minimal inhibitory concentrations and mycelial cell transformation in Candida albicans].
    Urbanowski S; Nierebińska E; Gwieździński Z
    Przegl Dermatol; 1989; 76(5-6):405-9. PubMed ID: 2561925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-Candida effects of estragole in combination with ketoconazole or amphotericin B.
    Shin S; Pyun MS
    Phytother Res; 2004 Oct; 18(10):827-30. PubMed ID: 15551395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of carvacrol and eugenol as prophylaxis and treatment of vaginal candidiasis in an immunosuppressed rat model.
    Chami F; Chami N; Bennis S; Trouillas J; Remmal A
    J Antimicrob Chemother; 2004 Nov; 54(5):909-14. PubMed ID: 15456732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of ketoconazole, itraconazole and fluconazole on the gastrointestinal colonization of mice by Candida albicans.
    Samonis G; Maraki S; Hajiioannou I; Chatzinikolaou I; Rolston KV; Bodey GP; Kontoyiannis DP
    J Chemother; 2001 Feb; 13(1):66-9. PubMed ID: 11233803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.